U.S. markets closed

Health Catalyst, Inc. (HCAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.27+1.04 (+6.41%)
At close: 04:00PM EDT
17.83 +0.56 (+3.24%)
After hours: 06:50PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close16.23
Bid16.96 x 1300
Ask17.84 x 1800
Day's Range15.99 - 17.29
52 Week Range11.25 - 59.50
Avg. Volume1,010,750
Market Cap935.775M
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-3.08
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.23
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HCAT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Health Catalyst, Inc
    PGNY: Raising target price to $36.00PROGYNY INC has an Investment Rating of BUY; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • PR Newswire

    Health Catalyst Powers $1.5 Billion in Validated Measurable Improvements

    Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has documented over 5.4 million lives positively impacted by improvement initiatives, $1.5 billion in validated measurable improvements, and 300 case studies – a result of its data and analytics technology, professional services, and deep customer relationships.

  • GlobeNewswire

    Health Catalyst to Participate in Upcoming Investor Conferences

    SALT LAKE CITY, June 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the following upcoming investor conferences: William Blair’s 42nd Annual Growth Stock Conference, being held in Chicago on Tuesday, June 7, 2022, inclu

  • Simply Wall St.

    Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price

    As you might know, Health Catalyst, Inc. ( NASDAQ:HCAT ) just kicked off its latest quarterly results with some very...